Thierry Wendling
Thierry Wendling
Domain Group
Verified email at domain.com.au
Title
Cited by
Cited by
Year
Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases
T Wendling, K Jung, A Callahan, A Schuler, NH Shah, B Gallego
Statistics in medicine 37 (23), 3309-3324, 2018
292018
Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles
SM Martins, T Wendling, VMF Gonçalves, B Sarmento, DC Ferreira
Journal of Chromatography B 880, 100-107, 2012
272012
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics
T Wendling, S Dumitras, K Ogungbenro, L Aarons
Journal of pharmacokinetics and pharmacodynamics 42 (6), 639-657, 2015
132015
Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects
T Wendling, K Ogungbenro, E Pigeolet, S Dumitras, R Woessner, ...
Pharmaceutical Research 32 (5), 1764-1778, 2015
122015
Reduction of a whole-body physiologically based pharmacokinetic model to stabilise the Bayesian analysis of clinical data
T Wendling, N Tsamandouras, S Dumitras, E Pigeolet, K Ogungbenro, ...
The AAPS journal 18 (1), 196-209, 2016
112016
Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data
T Wendling, H Mistry, K Ogungbenro, L Aarons
Cancer chemotherapy and pharmacology 77 (5), 927-938, 2016
102016
Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformations
N Tsamandouras, T Wendling, A Rostami-Hodjegan, A Galetin, L Aarons
Journal of pharmacokinetics and pharmacodynamics 42 (4), 349-373, 2015
92015
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population
N Tsamandouras, Y Guo, T Wendling, S Hall, A Galetin, L Aarons
Pharmacogenetics and genomics 27 (1), 27-38, 2017
72017
Development and validation of a methotrexate adherence assay
J Bluett, I Riba-Garcia, SMM Verstappen, T Wendling, K Ogungbenro, ...
Annals of the rheumatic diseases 78 (9), 1192-1197, 2019
52019
A HPLC-SRM-MS based method for the detection of adherence to low-dose oral methotrexate
J Bluett, T Wendling, K Ogungbenro, I Riba-Garcia, R Unwin, ...
Arthritis and Rheumatology 67 (S10), 1-2, 2015
12015
Hierarchical mechanistic modelling of clinical pharmacokinetic data
T Wendling
University of Manchester, 2016
2016
A HPLC-SRM-MS Based Method for the Detection of Adherence to Low-Dose Oral Methotrexate: Abstract Number: 1652
J Bluett, T Wendling, K Ogungbenro, I Riba-Garcia, R Unwin, ...
Arthritis & Rheumatology 67, 2043-2044, 2015
2015
Application of a Bayesian population approach to physiological modelling of mavoglurant pharmacokinetics
T Wendling, S Dumitras, R Woessner, E Pigeolet, K Ogungbenro, ...
Journal of Pharmacokinetics and Pharmacodynamics, 2015
2015
Supplementary material for the manuscript:“Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population”
N Tsamandouras, Y Guo, T Wendling, S Hall, A Galetin, L Aarons
Population Approach Group Europe Population Approach Group Europe
G Ma
The system can't perform the operation now. Try again later.
Articles 1–15